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ABSTRACT. Two diet-derived phenolic acids, caffeic and p-coumaric acids, interplayed with ascorbate in the
protection of low density lipoproteins (LDL) from oxidation promoted by ferrylmyoglobin. Ferrylmyoglobin, a
two-electron oxidation product from the reaction of metmyoglobin and H2O2, was able to oxidize LDL,
degrading free cholesterol and cholesteryl esters. Upon exposure to ferrylmyoglobin, LDL became rapidly
depleted of cholesteryl arachidonate and linoleate, which turn into the corresponding hydroperoxides.
Cholesteryl oleate and cholesterol were, comparatively, more resistant to oxidation. Caffeic (2 mM) and
p-coumaric (12 mM) acids efficiently delayed oxidations, as reflected by an increase in the lag times required for
linoleate hydroperoxide and 7-ketocholesterol formation as well as for cholesteryl linoleate consumption. At the
same concentration, ascorbate, a standard water-soluble antioxidant, was less efficient than the phenolic acids.
Additionally, phenolic acids afforded a protection to LDL that, conversely to ascorbate, extends along the time,
as inferred from the high levels of cholesteryl linoleate and cholesteryl arachidonate left after 22 hr of oxidation
challenging. Significantly, the coincubation of LDL with ascorbate and each of the phenolic acids resulted in a
synergistic protection from oxidation. This was inferred from the lag phases of cholesteryl linoleate hydroper-
oxide (the major peroxide found in LDL) formation in the presence of mixtures of ascorbate with phenolic acids
longer than the sum of individual lag phases of ascorbate and the phenolic acids. A similar description could be
drawn for the accumulation of a late product of oxidation, 7-ketocholesterol. It is concluded that ferrylmyoglobin
induces a typical pattern of LDL lipid peroxidation, the oxidation rate of cholesteryl esters being a function of
unsaturation; furthermore, there is a synergistic antioxidant activity of diet-derived phenolic acids with ascorbate
in the protection of LDL from oxidation, a finding of putative physiological relevance. BIOCHEM PHARMACOL
55;3:333–340, 1998. © 1998 Elsevier Science Inc.
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There is increasing evidence that oxidation of plasmatic
low density lipoproteins (LDL)§ is a critical factor in
promoting atherosclerosis [1]. Cholesterol and cholesteryl
esters are the main lipid components of human LDL [2]
and, apparently, these compounds are oxidized more rapidly
to hydroperoxides than the polyunsaturated phospholipids
in the outermonolayer [3, 4]. Thereafter, hydroperoxides
can decompose to reactive aldehydes that in turn may
modify amino acid residues of the apoB. The LDL particles
containing oxidatively modified apoprotein are recognized,
in the arterial wall, by the scavenger receptors in macro-
phages leading to uncontroled intracellular lipid accumu-
lation and transformation of the cells into lipid-laden foam
cells, which characterize the early lesions of atherosclerosis
[5]. On the other hand, oxygenated derivatives of free
cholesterol (oxysterols) possess a wide variety of biological
properties, including cytotoxicity [6]. Thus, the study of
LDL lipid peroxidation and its inhibition by antioxidants is
of considerable interest in the molecular mechanism of
atherosclerosis and in the design of active drugs to prevent
the disease.
Ferrylmyoglobin, a two-electron oxidation product from
the reaction of metmyoglobin with H2O2, initiates lipid
peroxidation in LDL, a process with putative significance in
vivo [7]. This strong oxidant derivative of myoglobin
contains two oxidizing centers, a relatively stable hyperva-
lent iron (FeIV 5 O), and a transient radical in the globin
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moiety [for review see 8], but detailed mechanisms and the
dynamics of the oxidation of LDL induced by ferrylmyoglo-
bin are still incipient. This hypervalent derivative of
myoglobin may be of physiological relevance in the ensuing
damage to LDL during the development of atherosclerosis.
On the other hand, a considerable effort is currently being
made to evaluate natural compounds that may act as
protective agents against oxidation of biological systems.
Recently, we reported that lipid peroxidation in LDL
induced by ferrylmyoglobin is prevented by dietary phe-
nolic acids, namely caffeic and p-coumaric acids [9]. The
underlying mechanisms encompass the reduction of fer-
rylmyoglobin to harmless metmyoglobin [10]. These com-
pounds are ubiquitously present in fruits and vegetables and
may be found in human plasma as a function of diet
concentration [11]. Moreover, there is in vitro evidence for
the scavenging activity of phenolic acids against free
radicals and chain-breaking antioxidant activity in LDL
particles [12]. However, the interplay of natural and “phys-
iological” antioxidants has not been addressed. Only re-
cently, the synergistic interaction of caffeic acid and a-
tocopherol, in the protection of LDL from oxidation,
explained in terms of the regeneration of a-tocopherol from
its radical, has been reported [13].
This work describes the time-courses of cholesterol,
cholesteryl linoleate, cholesteryl oleate and cholesteryl
arachidonate oxidations as well as the formation of cho-
lesteryl linoleate hydroperoxide and 7-ketocholesterol in
LDL challenged with ferrylmyoglobin, in an attempt to
understand the dynamics of ferrylmyoglobin-induced oxi-
dation. We also describe the concerted activity of selected
natural antioxidants, caffeic and p-coumaric acids, with
ascorbate on the rate of cholesteryl linoleate hydroperoxide
and 7-ketocholesterol formation in LDL peroxidation in-
duced by ferrylmyoglobin. A synergistic antioxidant effect
was shown to arise from the interplay of ascorbate with the
phenolic acids. The concerted electron transfer to fer-
rylmyoglobin by each of the antioxidants, reducing it to
harmless metmyoglobin, is an eventual molecular mecha-
nism underlying this effect, but reduction of caffeic and
p-coumaric acid radicals by ascorbate is suggested to occur.
MATERIALS AND METHODS
Reagents
Horse heart metmyoglobin, the phenolic acids, cholesterol,
7-ketocholesterol and the cholesteryl esters were obtained
from Sigma Chemical Co. Hydrogen peroxide was pur-
chased from Merck as a 30% solution. Ascorbate was
obtained from Fluka Chemika. Tetrasulphonated chloralu-
minium phtalocyanine was a gift from Ciba–Geiger. Before
use, metmyoglobin was purified by dialysis against phos-
phate buffer (20 mM phosphate, 110 mM NaCl), pH 7.4
(referred to as PBS) containing DTPA and Chelex. Stock
metmyoglobin and hydrogen peroxide solutions were stan-
dardized using e632nm 5 2.1 mM
21.cm21 and e240nm 5 43.6
M21.cm21, respectively. All solutions were prepared in
water purified in a Milli-Q apparatus. Ascorbate and
phenolic acids were dissolved in water.
LDL Isolation
LDL particles were isolated from fresh human blood of
healthy normolipidemic volunteers by a rapid isolation
method [14] using a Beckman L80 ultracentrifuge (Beck-
man Inst. Inc.) equipped with a Beckman 70.1 Ti fixed
angle rotor. The isolation of LDL, achieved by a discontin-
uous gradient density step (180 min), was followed by a
dialysis (against PBS) and a simultaneous concentration
step (45 min) by ultrafiltration through a collodium bag,
under nitrogen. Then, the LDL samples were sterile-filtered
through a 0.22-mm filter (Millipore), stored in the dark at
4° and used for the experiments within one week. The
protein content of LDL samples was measured according to
Lowry [15] using bovine serum albumin (BSA) as standard,
and the purity of LDL preparation was checked by SDS-
polyacrylamide gradient (3–20%) gel electrophoresis.
Oxidation Conditions
LDL samples (200 mg/mL) in PBS, pH 7.4, were incubated
at 37° under gentle stirring, and the oxidation reaction was
initiated by addition of 6 mM metmyoglobin/9 mM H2O2 in
the absence or presence of phenolic acids at the concen-
trations given in legends to figures. All the incubations
were performed in presence of 100 mM DTPA (stock
solution in PBS) to quelate trace transition metals, prevent-
ing hydroperoxide decomposition from Fenton-type reac-
tions. The oxidation reactions were stopped by addition of
20 mM butylated hydroxytoluene (final concentration)
from stock solution prepared in ethanol. LDL oxidation was
followed by the consumption of cholesterol and cholesteryl
esters and cholesteryl linoleate hydroperoxide (CL-OOH)
formation.
Analysis of Cholesterol, Cholesteryl Esters and
Cholesteryl Linoleate Hydroperoxide
Cholesterol, cholesteryl esters and cholesteryl linoleate
hydroperoxide in LDL samples were determined by HPLC
essentially as described by Kritharides et al. [16]. Briefly, 1
mL aliquots (200 mg of LDL protein) were withdrawn along
the incubation time, chilled in ice, spiked with 20 mM
BHT, and lipids extracted with methanol and n-hexane.
The hexane extracts were analyzed by HPLC on a Beck-
man-System Gold consisting of a 126 Binary Pump Model
and a 166 Variable UV Detector controled by a computer.
The column was a LiChrospher 100 RP-18 (5 mm) from
Merck. Cholesterol and cholesteryl esters were eluted with
a solvent mixture consisting of acetonitrile/isopropanol
(30/70, v/v), and cholesteryl linoleate hydroperoxide
(CL-OOH) and cholest-5-en-3b-ol-7-one (7-ketocholes-
terol, 7-KC) were eluted with acetonitrile/isopropanol/
water (44/54/2, v/v/v) at a flow rate of 1 mL/min. Analysis
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of these compounds was performed by UV detection at 210
or 234 nm for cholesterol and cholesteryl esters or cho-
lesteryl linoleate hydroperoxide and 7-ketocholesterol, re-
spectively.
CL-OOH standard was prepared photochemically by
irradiating the solution of cholesteryl linoleate in the
presence of tetrasulphonated chloraluminium phtalocya-
nine, as described by Thomas et al. [17] and quantified
according to Saadani et al. [18], using the molar absorptiv-
ity of iodine measured at 365 nm (e 5 2.46 6 0.25 3 104
M21 z cm21). This assay makes use of the oxidative capacity
of lipid peroxides to convert iodide to iodine, which can be
measured spectrophotometrically at 365 nm.
RESULTS
Time-Courses of Free Cholesterol and Cholesteryl Ester
Degradation and of Cholesteryl Linoleate Hydroperoxide
Formation in LDL Challenged with Ferrylmyoglobin
Oxidation of LDL promoted by ferrylmyoglobin induced a
rapid consumption of both cholesteryl arachidonate and
linoleate, as compared with the consumption of cholesteryl
oleate or free cholesterol (Fig. 1). Whereas cholesteryl
arachidonate and cholesteryl linoleate decreased after the
addition of ferrylmyoglobin (produced from metmyoglobin/
H2O2 mixture), cholesteryl oleate levels remained un-
changed for 6 hr and the degradation of free cholesterol was
negligible during the time of the experiment. After 10 hr,
cholesteryl arachidonate, linoleate and oleate in oxidized
LDL were 19, 47 and 82% of the initial values, respectively.
Therefore, the consumption rate was a function of the
degree of unsaturation of the ester acyl chain. These
oxidation profiles, in terms of consumption of cholesterol
and cholesteryl esters, promoted by ferrylmyoglobin in LDL
were qualitatively similar to those promoted by AAPH
(results not shown), a reference oxidant that generates
peroxyl radicals in the aqueous phase at a constant rate [19].
Cholesteryl linoleate hydroperoxide (CL-OOH), not
detected in the original LDL fraction, increased in parallel
with the loss of cholesteryl linoleate (CL), up to 6 hr of
oxidation challenge (Fig. 2). During the initial period (2
hr), CL was exclusively converted to the respective hy-
droperoxide, as indicated by the high correlation coeffi-
cient (r 5 0.98) of linear regression analysis of formed
cholesteryl linoleate hydroperoxide vs. cholesteryl linoleate
remaining in LDL particles (Fig. 2 inset). After a period of
8 hr, the relationship deviated from linearity, probably due
to CL-OOH decomposition. When the content of CL-
OOH reached its maximum value, a large amount of CL
still remained (ca. 50% of the initial amount).
Effects of Phenolic Acids and Ascorbate on the Time-
Courses of Cholesteryl Ester Consumption and
Cholesteryl Linoleate Hydroperoxide Formation
Under similar experimental conditions, the presence of
caffeic or p-coumaric acids, before addition of ferrylmyo-
globin to LDL solution, led to the inhibition of CL
consumption (Fig. 3A) and CL-OOH formation (Fig. 3B)
as a function of concentration. Caffeic acid, the most
efficient antioxidant, induced at 2 mM a lag phase of ca. 6
or 4 hr in the consumption of cholesteryl linoleate (Fig.
3A) or in the hydroperoxide formation (Fig. 3B), respec-
tively, an effect only observed at 12 mM p-coumaric acid.
FIG. 1. Time-courses of cholesterol and cholesteryl ester degra-
dation during oxidation of LDL by ferrylmyoglobin. LDL (200
mg protein/mL) were incubated with 6 mM metmyoglobin/9 mM
H2O2 in PBS containing DTPA (100 mM) for 10 hr, at 37°.
Free cholesterol (), cholesteryl arachidonate (}), cholesteryl
linoleate (h) and cholesteryl oleate (F) were analyzed by HPLC
along the oxidation time, and the amounts are expressed relative
to initial values before starting oxidations. Each point represents
the mean of triplicate determinations of separate experiments
performed with the same LDL preparation.
FIG. 2. Cholesteryl linoleate hydroperoxide formation (solid
line) and contents of cholesteryl linoleate (dashed line) in LDL
oxidized by ferrylmyoglobin. LDL aliquots (1 mL) were with-
drawn from the reaction mixture for lipid extraction and mea-
surement of cholesteryl linoleate and cholesteryl linoleate hy-
droperoxide by HPLC. Cholesteryl linoleate (CL) is expressed
relative to the initial value before starting oxidation, and cho-
lesteryl linoleate hydroperoxide is expressed as the ratio of
formed CL-OOH and the initial CL, as determined by the ratio
of the respective HPLC peak areas. The inset shows the linear
relationship of CL vs. CL-OOH up to 2 hr of reaction (r 5
0.98). Values represent the means of triplicate independent
experiments.
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Moreover, after this lag phase, along the incubation time, a
strong depression of the hydroperoxide formation rate was
observed (Fig. 3B). The incubation of LDL with metmyo-
globin (without H2O2) in the presence of p-coumaric or
caffeic resulted in the complete prevention of CL loss.
From Fig. 3 it is clear that, for identical concentrations (2
mM), caffeic acid exhibited a significantly higher protective
effect against ferrylmyoglobin-mediated LDL oxidation
over ascorbate, the major water-soluble antioxidant in
plasma [20]. Indeed, 2 mM ascorbate only slightly inhibited
CL-OOH formation, comparable to the effects of 1 mM
caffeic or 6 mM p-coumaric acid (Fig. 3B). Conversely to 2
mM caffeic acid, 2 mM ascorbate did not effectively inhibit
ferrylmyoglobin-mediated LDL oxidation; after 10 hr incu-
bation, the cholesteryl linoleate loss in LDL particles
amounted to 50 and 53% of total in the presence or absence
of 2 mM ascorbate, respectively (Fig. 3A). To better
evaluate the independent antioxidant activities of ascor-
bate, caffeic and p-coumaric acids, a dose-response curve
based on the accumulation of CL-OOH is included as an
inset to Fig. 3A. The estimated IC50 values of caffeic acid,
ascorbate and p-coumaric acid, within an experimental
error of 5%, were 1.9, 5.2 and 14.4 mM, respectively.
After 22 hr oxidation (Fig. 4) challenged by 6 mM
metmyoglobin/9 mM H2O2 (corresponding to an extensive
LDL oxidation), approximately only 20% of CL was left in
LDL and CA was not detected; ascorbate did not effectively
prevent these losses. In fact, 73.5 and 98% of cholesteryl
linoleate and cholesteryl arachidonate, respectively, were
lost despite the presence of 2 mM ascorbate. In contrast,
only 39 and 63% of the same esters were lost when 2 mM
caffeic acid was present. In general, the differences between
the protective effects of 2 mM caffeic acid and 12 mM
p-coumaric acid were minor and not significant. The results
summarized in Fig. 4 point out that the protection afforded
by these phenolic acids extended along the time, in
contrast to the effect of ascorbate that was negligible at
later times.
Moreover, caffeic and p-coumaric acids, at the indicated
concentrations, fully protected the degradation of free
cholesterol in LDL challenged with ferrylmyoglobin during
the experimental time (Fig. 5). It is also clear from Fig. 5
that the phenolic acids increased, up to 6 hr, the lag phase
of CO disappearance, and, after the lag phases, clearly
decreased the degradation rate of cholesteryl oleate.
FIG. 3. Effects of caffeic acid, p-coumaric acid and ascorbate on
the rates of cholesteryl linoleate contents (A) or cholesteryl
linoleate hydroperoxide formation (B) in LDL oxidized by
ferrylmyoglobin. Aliquots were withdrawn from the reaction
mixture, processed, and analyzed by HPLC. Symbols: (E)
control (no antioxidant addition), (F) caffeic acid (2 mM), ()
p-coumaric acid (12 mM), (n) ascorbate (2 mM), () caffeic
acid (1 mM) and () p-coumaric acid (6 mM). The antioxidants
were added 3 min before starting the oxidation reaction with
H2O2. Each point represents the mean of duplicate determina-
tions in independent experiments. Cholesteryl linoleate and the
respective hydroperoxide are expressed as indicated in the legend
to Fig. 2. A dose-response curve for the three antioxidants is
included as inset to Fig. 3A. Measurements were made after 10
hr incubation. A linear correlation coeficient >0.90 was
achieved for all the compounds. Each point represents the mean
of two independent measurements within an experimental error
of 5%.
FIG. 4. Effect of caffeic acid, p-coumaric acid and ascorbate on
the contents of cholesteryl arachidonate (white bars) or linoleate
(black bars) remaining in LDL at 22 hr incubation in the
presence of ferrylmyoglobin. Results are expressed relative to
the initial contents of esters before starting oxidation. In the
control assay (absence of phenolic acids), cholesteryl arachido-
nate is below the detection limit. When present, phenolic acids
were added, at the indicated concentrations, 3 min before
starting the oxidation reaction. Error bars are not given since the
values are taken from a single representative set of experiments
with the same LDL aliquot and stock solutions of phenolic acids,
ascorbate, metmyoglobin and H2O2. Experimental uncertainties
were negligible.
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Synergistic Effect between Caffeic or p-Coumaric Acids
with Ascorbate in Ferrylmyoglobin-Mediated
LDL Oxidation
In the isolated LDL fraction, not exposed to oxidation,
CL-OOH and 7-KC (a product of later peroxidation) were
not detectable. In LDL incubated with ferrylmyoglobin,
CL-OOH content reached a maximum level at ca. 8 hr
(Fig. 6), but 7-KC reached a maximum level only after 22
hr incubation (Fig. 7). In Figs. 6 and 7 for the control assays
(in absence of phenolic acids), lag phases for CL-OOH and
7-KC were absent. However, in presence of caffeic (2 mM)
or p-coumaric (12 mM) acids a lag phase of ca. 4 or 6 hr was
clearly exhibited, in contrast to ascorbate that fails to
induce an inhibition period of oxidation (Figs. 6 and 7).
Moreover, the rates of formation of oxidized products
decreased in presence of either phenolic acids or ascorbate.
The protection afforded by ascorbate (4 mM) on 7-KC
formation was considerably lower than that of caffeic or
p-coumaric acids, at the concentrations used (Fig. 7).
However, when caffeic or p-coumaric acids were added
together with ascorbate, an inhibition period of oxidation
of ca. 12 hr for the formation of CL-OOH was measured;
this period was considerably longer than that expected from
the sum of the periods observed in the presence of phenolic
acids and ascorbate separately (Fig. 6). Similar effects were
observed when the formation of 7-KC (Fig. 7) was mea-
sured. From this figure, it is clear that ascorbate potentiated
the protection of either caffeic or p-coumaric acids against
LDL oxidation, significantly increasing the inhibition pe-
riods of 7-KC formation. Figures 6 and 7 also document
that, after the lag phase, the formation rates of 7-KC were
depressed to a higher extent as compared to CL-OOH
formation. On the other hand, the presence of caffeic and
p-coumaric acids together induced inhibition periods not
significantly different from the sum of periods induced by
each phenolic acid separately (not shown).
Therefore, there exists a synergistic effect of the phenolic
acids with ascorbate and a mere additive effect of the
phenolic acids, in the absence of ascorbate, on LDL
peroxidation challenged by ferrylmyoglobin.
DISCUSSION
The concentrations of lipid hydroperoxides in LDL in
normal healthy subjects are rather low [17]. Although
controversial, it has been reported that most plasma hy-
droperoxides are conveyed in LDL [21] rather than in high
FIG. 5. Effects of caffeic and p-coumaric acids on free choles-
terol and cholesteryl oleate contents in LDL oxidized as de-
scribed in the legend of Fig. 1. Aliquots (1 mL) were removed
for lipid extraction and HPLC analysis of free cholesterol (solid
lines) and cholesteryl oleate (dashed lines). The concentrations
of free cholesterol and cholesteryl oleate in starting LDL were
840 and 337 nmol/mg LDL protein, respectively. Symbols: (E)
control (absence of phenolic acids), (F) caffeic acid (2 mM) and
() p-coumaric acid (12 mM) added 3 min before starting
oxidation.
FIG. 6. Effects of caffeic or p-coumaric acids associated with
ascorbate on the formation rate of cholesteryl linoleate hy-
droperoxide in LDL oxidized by ferrylmyoglobin. Symbols: (})
control (absence of antioxidants), ({) ascorbate (4 mM), (n)
caffeic acid (2 mM), (E) 2 mM caffeic acid plus 4 mM ascorbate,
(F) p-coumaric acid (12 mM) and () 12 mM p-coumaric acid
plus 4 mM ascorbate added before starting oxidation. Cho-
lesteryl linoleate hydroperoxide is expressed as indicated in the
legend for Fig. 2.
FIG. 7. Effects of caffeic or p-coumaric acids on 7-ketocholes-
terol formation in LDL exposed to ferrylmyoglobin in the
absence and presence of ascorbate. LDL aliquots were extracted
and analyzed by HPLC. Symbols: (}) control (absence of
antioxidants), ({) ascorbate (4 mM), (F) p-coumaric acid (12
mM), (n) caffeic acid (2 mM), (E) 2 mM caffeic acid plus 4 mM
ascorbate and () 12 mM p-coumaric acid plus 4 mM ascorbate
added before oxidation.
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density lipoprotein fraction [22]. Several studies provide
evidence for a robust positive correlation between the
severity of atherosclerosis and plasmatic hydroperoxide
concentration [23]. Moreover, the toxicity of oxidized LDL
is apparently related to the amount of hydroperoxide
carried by the oxidized LDL [24].
Ferrylmyoglobin initiates lipid peroxidation in several
lipid systems, including LDL [25]. Since the most abundant
cholesteryl ester in LDL is cholesteryl linoleate, measure-
ment of its hydroperoxides is, in principle, a sensitive
indicator of lipid peroxidation during oxidation of LDL by
ferrylmyoglobin, and its suppression by dietary phenolic
acids a clear indication of antioxidant activity.
The time-courses of cholesterol and cholesteryl ester
depletion promoted by ferrylmyoglobin have been mea-
sured. Data indicate that ferrylmyoglobin is able to oxidize
cholesteryl esters and free cholesterol in LDL, inducing a
typical profile of LDL cholesteryl ester oxidation; the rate of
oxidation is a function of unsaturation and follows the
order: cholesteryl arachidonate . cholesteryl linoleate .
cholesteryl oleate . free cholesterol (Fig. 1). These results
are consistent with those reported recently by Brown et al.
[26] for Cu21-oxidized LDL. Further, oxidation of LDL by
ferrylmyoglobin or via azoperoxyl radicals (results not
shown) yields identical product profiles representing cho-
lesterol and cholesteryl esters loss or cholesteryl linoleate
hydroperoxide formation, despite putative differences in
the mechanisms of oxidation of these prooxidants.
In ferrylmyoglobin-challenged LDL, the cholesteryl li-
noleate hydroperoxide, not detectable in the original LDL
fraction, increases in parallel with the loss of cholesteryl
linoleate and, during the initial 2 hr period, the decrease in
CL is essentially related to the formation of CL-OOH (Fig.
2). Since CL-OOH is a major product of ferrylmyoglobin-
catalyzed LDL oxidation, it was used to evaluate the
interplay between the phenolic acids and ascorbate on the
protection of LDL from lipid peroxidation.
The health benefit of phenolic acids as antioxidants is a
current interesting trend [11, 12]. The plant metabolites
caffeic and p-coumaric acids are chemically related (caffeic
acid is a cathecol and p-coumaric is a monophenol) but
exhibit very different antioxidant activities [13]. Caffeic
and p-coumaric acids have a marked effect on the time-
courses of cholesterol and cholesteryl esters degradation
(Figs. 3A, 4 and 5) and the formation of cholesteryl
linoleate hydroperoxide (Fig. 3B) in LDL oxidized by
ferrylmyoglobin. These effects are expressed by increased
lag times of linoleate hydroperoxide formation (Fig. 3B)
and disappearance of cholesteryl esters (Fig. 3A) and also
by a significant decrease in the rate of oxidation. Further-
more, the protective effect of these phenolic acids still
persists after long periods of oxidative challenging (Fig. 4).
It is particularly interesting that caffeic acid markedly
inhibits ferrylmyoglobin-mediated LDL oxidation as com-
pared with ascorbate at the same concentration. It was
previously shown that ascorbate [27, 28], caffeic and p-
coumaric acids [10] reduce ferrylmyoglobin back to met-
myoglobin. Thus, the independent antioxidant activities of
these compounds in suppression of ferrylmyoglobin-induced
LDL lipid peroxidation are related to these reduction
abilities. Caffeic acid is a better antioxidant than p-
coumaric acid in ferrylmyoglobin-dependent LDL oxida-
tion (Fig. 3A and B), a finding that is presumably related to
the increased efficiency of caffeic over p-coumaric acid in
reducing ferrylmyoglobin to metmyoglobin [10], a species
harmless to LDL in absence of endogenous hydroperoxides.
In agreement with this reduction ability, caffeic acid is a
stronger scavenger of peroxyl radicals in the LDL system
[12] as compared with p-coumaric acid.
The antioxidant activities of these compounds depend
on the rate constants of the above-mentioned reactions and
on the reactivity of phenoxyl radicals formed as products of
the “antioxidant reaction”. The p-coumaric acid is a less
efficient radical scavenger than caffeic acid, a fact that may
be ascribed to the increased radical stability of o-semiqui-
none radical of caffeic acid relative to the radical p-
coumaric acid [29]. Recently, we reported that caffeic acid,
like ascorbate, can regenerate a-tocopherol from the a-
tocopheroxyl radical at the LDL surface but, in contrast,
that p-coumaric acid potentiates a-tocopherol consump-
tion [13]. The p-coumaric behavior can be explained by the
high reactivity of its phenoxyl radical (produced by an
electron-transfer reaction between the phenolic acid and
ferrylmyoglobin) with a-tocopherol. Indeed, it was recently
shown that simple phenoxyl radicals are highly reactive
towards a-tocopherol, oxidizing it [30]. Therefore, recy-
cling of phenoxyl radicals from caffeic and p-coumaric acids
by ascorbate, thereby yielding the very stable ascorbyl
radical that terminates in the aqueous phase by dispropor-
tionation [31], would prevent eventual toxic effects of the
phenolic compounds, increasing LDL protection against
oxidation.
This synergistic interplay is well documented in Figs. 6
and 7, on the basis of the following events: (a) the presence
of ascorbate does not delay the onsets of CL-OOH and
7-KC formation, but only slows down the rates; (b) when
ascorbate is added together with caffeic or p-coumaric acids,
the onsets are significantly delayed relative to the periods
observed in the presence of phenolic acids alone. Ascorbate
without effect, per se, increases the inhibition period of the
phenolic acids from ca. 5 hr to 12 hr. This event is
presumably a consequence of phenolic acid regeneration
promoted by ascorbate. Of course, this does not exclude the
individual reactions of each of the three antioxidants in
reducing ferrylmyoglobin to metmyoglobin, thus contribut-
ing to the overall antioxidant activity. The reaction be-
tween ascorbate and phenolic acids is kinetically (the
compounds are located in the same compartment) and
thermodynamically feasible (ascorbyl radical exhibits lower
reduction potential than caffeic and p-coumaric radicals
[32, 33]).
Recent in vivo data have demonstrated that oxysterols,
including 7-KC (a product of later lipid oxidation), accu-
mulate in human foam cell macrophages from the athero-
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sclerotic plaque [34]. 7-KC is the major oxysterol present in
ox-LDL-loaded cells, comprising approximately 60% of all
oxysterols [34]. Gelissen et al. [35] reported that 7-KC may
promote foam cell formation in vivo through inhibition of
reverse sterol transport [35], a mechanism by which periph-
eral cells export excess cholesterol to an extracellular
acceptor. Therefore, this compound is presumably critical
to atherogenesis because it inhibits cholesterol removal
from cells and is cytotoxic. In fresh LDL samples, 7-KC is
not detectable and shows up along the time when LDL are
exposed to ferrylmyoglobin. Therefore, ferrylmyoglobin-
mediated LDL oxidation generates advanced oxidation
products of the type identified in human atherosclerotic
plaque.
The 7-KC was particularly sensitive to the presence of
metals, and its generation is apparently dependent on a
redox cycle of metals [36]. Ferrylmyoglobin contains iron in
the heme moiety, and at later oxidation steps can be
released to the medium, thus potentiating 7-KC formation.
Therefore, since phenolic acids may bind transition metals
[37], it is conceivable that ascorbate plus p-coumaric or
caffeic and caffeic plus p-coumaric acids may suppress the
generation of 7-KC more efficiently than that of CL-OOH.
In summary, LDL lipid peroxidation initiated by fer-
rylmyoglobin involves the degradation of cholesteryl esters
as a function of unsaturation. The phenolic acids and
ascorbate inhibit these reactions, the inhibition being
strongly increased by the concerted activity of ascorbate
with the phenols. Owing to the negative health impact of
atherosclerosis in western societies, dietary phenolic acids
may significantly improve public health as promising anti-
atherogenic agents. Further effort has to be made in terms
of the bioavailabity and pharmacokinetics of these hy-
droxycinnamic plant metabolites. Since these phenolics
occur ubiquitously in the plant kingdom, they are con-
sumed in human diet in various amounts. Therefore, they
may reach the plasma as a function of diet. In fact, a
Na1-dependent saturable transport of cinnamic acid across
the brush-border membrane of rat jejunum has recently
been described [38]. This study provides in vitro evidence for
a very effective mechanism contributing to the prevention
of LDL lipid peroxidation that may have pathophysiologi-
cal relevance in atherosclerosis: a synergistic antioxidant
effect of caffeic and p-coumaric acids with ascorbate.
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